Analisa Pola Penggunaan Dan Ketepatan Dosis Obat Pasien Stroke Iskemik Di Rsud Mardi Waluyo Kota Blitar

Erni Anika Sari, Shofiatul F, Esti Ambarwati W, Vira Yunita

Abstract


Stroke is an acute manifestation of a deficit or disturbance of function of the nervous system that persists for ≥ 24 hours and is caused by cerebral circulation disorders. Ischemic stroke occurs in 80% of patients diagnosed with stroke, which is a blockage in a blood vessel due to an embolism or thrombus. The multifactorial causes of stroke mean that there is no treatment that is totally effective in overcoming the disease, so that stroke treatment itself is referred to as integrated treatment. The aim of this study was to determine the pattern of use and dosage accuracy of ischemic stroke drugs which include fibrinolytic, anticoagulant, antiplatelet, antihypertensive and neuroprotectant groups for inpatients at Mardi Waluyo Hospital, Blitar City. This research method is descriptive and data collection is based on medical record data of stroke patients undergoing hospitalization at Mardi Waluyo Hospital for the year 2022. The results of the study obtained 113 sample data showing patterns of use of the most frequently used class of drugs, namely the Antiplatelet + combination Neuroprotectant in 29% (33 patients) and single class Antiplatelet in 13% (15 patients). The antiplatelets that the patient got were Aspirin, Clopidogrel and a combination of both. Evaluation of dosage accuracy based on the 2019 AHA found innaccurate Telmisartan and Citicoline dosages.

Keywords


Ischemic Stroke; Dosage; Drugs

Full Text:

PDF

References


Kemenkes, Pedoman Nasional Pelayanan Kedokteran Tata Laksana Stroke. 2019, hlm. 1–151.

V. L. Feigin dkk., “World Stroke Organization ( WSO ): Global Stroke Fact Sheet 2022,” vol. 17, no. X, 2022, doi: 10.1177/17474930211065917.

Riskesdas, Hasil Riset Kesehatan Dasar Nasional. 2018.

T. Ackerson dkk., AHA / ASA Guideline Guidelines for the Early Management of Patients With Acute Ischemic Stroke : 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. 2019. doi: 10.1161/STR.0000000000000211.

R. Anggraini, V. Y. F, M. A. Masruhim, L. Penelitian, dan F. Tropis, “Terapi Penggunaan Obat Stroke pada pasien stroke iskemik di RSUD Abdul Wahab Sjahranie Samarinda,” dalam Prosisding Seminar Nasional Kefarmasian Fakultas Farmasi Universitas Mulawarwan Samarinda, 2020, hlm. 20–21.

S. Vurumadla, V. Rakshith, M. Ch, dan K. Venkateshwarlu, “Innovare Academic Sciences A STUDY ON SYMPTOMS , RISK FACTORS AND PRESCRIBING PATTERN OF DRUGS USED IN STROKE PATIENTS,” vol. 7, no. 1, hlm. 12–17, 2015.

Kemenkes, Modul penggunaan obat rasional. 2011, hlm. 1–175.

T. Hariyanti, Y. S. Prabandari, U. G. Mada, dan E. Health, “Health Seeking Behaviour pada Pasien Stroke Health Seeking Behaviour pada Pasien Stroke Health Seeking Behavior on Stroke Patients,” no. February, 2015, doi: 10.21776/ub.jkb.2015.028.03.15.

V. Azzahra dan S. Ronoatmodjo, “Faktor-Faktor yang Berhubungan dengan Kejadian Stroke pada Penduduk Usia > 15 Tahun di Provinsi Daerah Istimewa Yogyakarta ( Analisis Riskesdas 2018 ),” vol. 6, no. 2, 2022.

C. A. Dinata, Y. Syafrita, dan S. Sastri, “Gambaran Faktor Risiko dan Tipe Stroke pada Pasien Rawat Inap di Bagian Penyakit Dalam RSUD Kabupaten Solok Selatan Periode 1 Januari 2010 - 31 Juni 2012,” vol. 2, no. 2, 2013.

D. G. Hackam dan J. D. Spence, “Antiplatelet Therapy in Ischemic Stroke and Transient Ischemic Attack,” hlm. 773–778, 2019, doi: 10.1161/STROKEAHA.118.023954.

A. Roman-gonzalez dkk., “Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia,” vol. 2021, 2021.

J. Shah, S. Liu, dan W. Yu, “Contemporary antiplatelet therapy for secondary stroke prevention : a narrative review of current literature and guidelines,” 2022, doi: 10.1136/svn-2021-001166.

A. R. Sherief Ghozy, “Neuroprotection in Acute Ischemic Stroke : A Battle Against the Biology of Nature,” vol. 13, no. May, hlm. 1–17, 2022, doi: 10.3389/fneur.2022.870141.

K. Overgaard, “The Effects of Citicoline on Acute Ischemic Stroke : A Review,” Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 7, hlm. 1764–1769, 2014, doi: 10.1016/j.jstrokecerebrovasdis.2014.01.020.

A. Agarwal dkk., “Citicoline in acute ischemic stroke : A randomized controlled trial,” vol. d, hlm. 1–12, 2022, doi: 10.1371/journal.pone.0269224.

D. A. Juwita, D. Almasdy, dan T. Hardini, “Evaluasi Penggunaan Obat Antihipertensi pada Pasien Strok Iskemik di Rumah Sakit Strok Nasional Bukittinggi Evaluation of Antihypertensive Drug Use on Ischemic Stroke Patients at National Stroke Hospital Bukittinggi,” vol. 7, no. 2, 2018, doi: 10.15416/ijcp.2018.7.2.99.




DOI: https://doi.org/10.37311/ijpe.v3i3.24219

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 erni anikasari

Creative Commons License
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.